Drimva

Novartis

Associate Director, Content Approval Operations

$153K–$283K

East Hanover · Director · Full-time · Posted Oct 27, 2026

Experience
5+ years in pharmaceutical marketing operations or pharmaceutical content approval; at least one year of people leadership or team lead experience.
Education
Bachelor’s degree required in Business, Marketing, Communications, Information Management, or related discipline; advanced degree preferred.

About the job

Leads content approval operations for claims, references, and Material Approval Process workflows, ensuring compliant execution, team coordination, and process improvement.

What you'll do

  • Oversee claims and reference governance and progression through the Material Approval Process, maintaining quality, traceability, and accurate metadata.
  • Coordinate team priorities, workload, coverage, coaching, and escalations across claims, references, and approval enablement.
  • Monitor operational performance and partner cross-functionally to improve workflows, including through AI-assisted capabilities and automation.

What they ask for

  • Bachelor’s degree in Business, Marketing, Communications, Information Management, or a related discipline.
  • 5+ years of experience in pharmaceutical marketing operations or pharmaceutical content approval, with strong understanding of FDA promotional regulations and MAP/MLR review processes.
  • At least one year of people leadership of direct reports or team lead experience.
  • Experience with content approval and DAM platforms; operational metrics, dashboards, and performance data.

Nice to have

  • Advanced degree.
  • Experience integrating AI or automation into operational workflows.

Pay

USD $152,600 and $283,400 per year (base salary); USD $152,600.00 - $283,400.00 (base salary)

Tools

Veeva, Aprimo

AI focus

Apply foundational AI and automation to improve compliance and efficiency in operational workflows; AI literacy and critical thinking with compliance judgment are required.

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 5, 2026 (UTC)